Frekil
Evidence in minutes, not months
San Francisco, California, US
Frekil is an AI-powered platform for pharmaceutical and biotech companies, automating real-world evidence (RWE) generation from EHR and claims data. It also features a Medical Imaging Data Platform that provides AI-assisted annotation, significantly speeding up medical image processing.
Problem Statement
Pharma companies lose $100M - $1B annually due to inefficient real-world evidence generation.
Core Technology
AI-powered real-world evidence platform; AI-assisted medical imaging annotation.
Key Differentiators
Reduces RWE study timelines from 12-18 months to minutes; Automated statistical analysis plan (SAP) generation aligned with regulatory standards; Propensity score matching, cohort selection, and regression modeling capabilities; Generates publication-ready results including tables, graphs, KM curves, and Forest plots; Generates external control arms for clinical trials; 10x faster annotation cycles for medical imaging compared to traditional approaches; FDA-ready annotation tools with versioning, consensus checks, and audit trails; Full auditability and audit trails for regulatory compliance
Clinical Focus
Medical Imaging; Clinical Research; Radiology; Biostatistics
Company Info
- Business Model
- B2B SaaS
- Founded
- 2024
- Total Funding
- 500,000
- Website
- www.frekil.com
Categories
Disease Areas
Technologies
Clinical & IP
Clinical Validation
FDA-aligned study protocols, OMOP CDM standardization, full audit trails, HIPAA/GDPR compliant architecture with air-gapped design ensuring no clinical data touches AI.
MedStartr Index Score
?What do you think of Frekil?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.